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Virus  entry  into  host  cells relies  on  interactions  between  viral  and  host  structures  including  lipids,  carbo-
hydrates  and  proteins.  Particularly,  protein–protein  interactions  between  viral surface  proteins  and  host
proteins  as  well  as secondary  host  protein–protein  interactions  play  a pivotal  role  in  coordinating  virus
binding  and  uptake.  These  interactions  are  dynamic  and  frequently  involve  multiprotein  complexes.
In  the  past  decade  mass  spectrometry  based  proteomics  methods  have  reached  sensitivities  and  high
throughput  compatibilities  of  genomics  methods  and  now  allow  the  reliable  quantitation  of  proteins  in
complex  samples  from  limited  material.  As  proteomics  provides  essential  information  on  the  biologi-
cally  active  entity  namely  the  protein,  including  its posttranslational  modiﬁcations  and its  interactionsuantitative proteomics
rotein interaction networks
with  other  proteins,  it is  an  indispensable  method  in  the  virologist’s  toolbox.  Here  we  review  protein
interactions  during  virus  entry  and  compare  classical  biochemical  methods  to  study  entry  with  novel
technically  advanced  quantitative  proteomics  techniques.  We  highlight  the  value  of  quantitative  pro-
teomics  in  mapping  functional  virus  entry  networks,  discuss  the  beneﬁts  and  limitations  and  illustrate
how  the  methodology  will  help  resolve  unsettled  questions  in  virus  entry  research  in  the  future.
© 2015  The  Authors.  Published  by  Elsevier  B.V.  This  is  an  open  access  article  under the  CC  BY-NC-ND. Protein–protein interactions during virus entry
Viruses need to enter permissive host cells in order to propagate
nd spread. The penetration of cells requires an initial interaction
f viral and host surface structures. Typical viral attachment pro-
eins (VAP) are transmembrane glycoproteins for enveloped viruses
r capsid proteins for naked viruses. Alternatively, some viruses
ncorporate phosphatidylserine into their envelope and use this
ipid for host cell interaction (Amara and Mercer, 2015; Jemielity
t al., 2013; Kondratowicz et al., 2011; Mercer and Helenius, 2008;
oller-Tank et al., 2013; Shimojima et al., 2012). For the majority
f viruses, however, proteins bind to cellular receptors, i.e., pro-
eins or carbohydrates, and the expression of a particular receptor
s often determining tissue and species tropism of a virus. In this
eview we focus on the role of protein–protein interactions (PPI)
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during viral penetration as protein–lipid and protein–carbohydrate
interactions in cell entry of viruses have been discussed elsewhere
(Amara and Mercer, 2015; Lozach et al., 2007; Stencel-Baerenwald
et al., 2014).
Historically, the ﬁrst virus receptor found was a glycan. In 1981
Helenius and coworkers described sialic acid as the inﬂuenza A
virus receptor (Matlin et al., 1981). In the following years it became
clear that most virus receptors are proteins or protein-linked
entities, such as glycosaminoglycans. As a consequence, protease
treatment rendered susceptible host cells non-susceptible for many
viruses. With the discovery of CR2 as Epstein Barr virus (EBV) and
CD4 as human immunodeﬁciency virus type 1 (HIV-1) receptor
the hunt for virus receptors began (Fingeroth et al., 1984; Maddon
et al., 1986). Since then technological developments like antibody
based afﬁnity puriﬁcation (AP), mass spectrometry (MS) of pro-
teins, DNA mediated transformation and molecular cloning led to
the discovery of dozens of receptors for human pathogenic viruses
(Fig. 1). Nevertheless, for many viruses the cognate receptor(s)
remain enigmatic and a “one ﬁts all” method for their discovery
has not yet been described.
Virus entry factors, which interact with VAPs directly, can be
differentiated into attachment factors and entry receptors. Attach-
ment factors facilitate entry by concentrating the virus on the cell
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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aFig. 1. Timeline of the milestones in virus entry 
urface. Virus receptors not only mediate cell attachment but the
PI of VAP and receptor also guides subsequent entry steps, e.g.
nternalization (Fig. 2 and Box 1). Sometimes the VAP- receptor
nteraction unleashes the fusogenic property of viral glycoproteins
y inducing conformational changes in the VAP ectodomains. A
ell-studied example is the priming of the hepatitis C virus (HCV)
lycoprotein E2 by the CD81 receptor (Sharma et al., 2011). For
iruses, which fuse in intracellular vesicular compartments, a drop
n pH typically acts as primer for fusion. In some cases host pro-
eases interact with and cleave VAPs rendering them fusogenic.
ig. 2. Schematic representation of virus entry pathways. PPIs between viral and
ellular factors orchestrate viral attachment, trafﬁcking, fusion and uncoating. Clas-
ical virus infection pathways are illustrated for a generic enveloped virus. Note that
aked virions infect cells in a similar manner with viral capsid proteins mediating
ritical PPIs with cellular proteins (not shown). PPIs facilitating virus attachment,
urﬁng, fusion and transport are depicted. In some cases proteolytic processing
ediated by host factors triggers viral membrane fusion. Moreover, secondary PPIs
an  lead to assembly of multiprotein receptor platforms that allow internalization
nd ultimately membrane fusion.ch and pioneering MS  technology development.
Proteolytic processing of VAPs either occurs during VAP biosyn-
thesis or during virus entry. The latter applies to ebola virus, which
requires processing of its envelope glycoprotein by cathepsins
in endosomes (Chandran et al., 2005). Moreover, interactions of
VAPs with secondary receptors, occurring after membrane surﬁng
of viruses towards cellular junctions may  trigger internalization
(Coyne and Bergelson, 2006). After endocytosis, secondary PPIs
with endosomal receptors can in addition to the pH drop ren-
der viral glycoproteins fusogenic (Carette et al., 2011; Cote et al.,
2011). Subsequently viruses replicating in the nucleus are trans-
ported along the cytoskeleton towards the nuclear pore, where the
genome is released into the nucleus. Transport relies again on PPI
of virus structural proteins and microtubular motor proteins. All
viruses additionally need to undergo uncoating, i.e., the viral nucle-
ocapsid needs to disassemble to release the genome into the cell.
Uncoating is poorly understood for most viruses, but as detailed
below, also requires interaction of viral capsids with host proteins.
Fig. 2 highlights the most important steps in virus entry and critical
PPI for each step.
In brief, most processes during virus entry are coordinated by
PPIs. In fact, eighty percent of the approximately 20,000 protein
coding genes of a cell are estimated to perform their function
through interactions with other proteins. Roughly 10,000 dis-
tinct interaction types, i.e., structurally similar interactions, and
130,000–650,000 binary protein interactions can occur in a cell
(Aloy and Russell, 2004; Stumpf et al., 2008; Venkatesan et al.,
2009). Thus, knowledge on protein complexes is essential for the
understanding of cellular mechanisms and for the targeted interfer-
ence with a protein’s function. In some instances this knowledge
has been successfully translated into therapeutic approaches for
treatment of viral infections. The best known examples are the
HIV-1 CCR5 coreceptor antagonist maraviroc and the HIV-1 gp41
fusion inhibitors (Dorr et al., 2005; Wild et al., 1993). Impor-
tantly, many interactions are mediated by short 10 amino acid
long unstructured peptide motifs, are transient, and have rela-
tively low afﬁnity. Classical high stringency tandem AP protocols
thus often missed peptide motif based protein interactions. Novel
shotgun proteomics of one step afﬁnity enriched samples provides
now the opportunity to unravel a multitude of previously missed
interactions. Typical host peptide motifs, which coordinate PPIs
and occur in several hundred human proteins, are the functional
unit of src-homology 2 domain (SH2-domain), SH3-domain, the
post synaptic density protein (PSD95), Drosophila disc large tumor
suppressor (Dlg1), and zonula occludens-1 protein (zo-1)-domain
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Box 1: Deﬁnitions and abbreviations in virus entry.
Susceptible cell: cell that expresses virus receptors and entry
factors and thus allows entry of a virus.
Permissive cell: cell that expresses all host factors required
for replication, assembly and release of a virus and thus can
generate infectious progeny after infection.
Virus entry: process of delivery of the viral genome to the
viral replication compartment in the cells. Depending on the
replication site and the virus entry route, virus entry includes
cell attachment, endocytosis, membrane penetration, trafﬁck-
ing in the cytoplasm, nuclear import, release of viral structural
proteins like tegument and genome uncoating.
Virus attachment factor: cell surface protein interacting
with a virus. Attachment factors facilitate entry by concentrat-
ing virions at the cell surface and can promote subsequent
interactions with entry receptors.
Virus entry receptor: cellular protein, lipid or glycan that
binds the virus particle and mediates virus uptake and/or trig-
gers critical conformational changes crucial for infection. Viral
receptors are often localized to the plasma membrane, but can
also reside in endosomal compartments.
Virus entry factor: operationally deﬁned as any cellular fac-
tor that in some way participates in the virus entry process, but
not necessarily interacts with the virus.
Viral attachment protein (VAP): viral surface protein that
binds to the virus receptor. VAPs of enveloped viruses are
transmembrane glycoproteins, while VAPs of naked viruses
are viral capsid proteins.
Capsid (also: Core): protein shell of a virus arranged around
the viral genome or complexed to it; build by repeat units of
single proteins or protein complexes. The capsid proteins are
encoded by the viral genome.
Nucleocapsid: complex of viral genome and capsid, which
may  for enveloped viruses be surrounded by a lipid bilayer.
Envelope (also: Peplos): host cell derived lipid bilayer sur-
rounding the nucleocapsid of enveloped viruses. The envelope
typically displays viral genome encoded transmembrane pro-
teins. These envelope proteins are VAPs and in some cases
enzymes (neuraminidases) that cleave cellular carbohydrates
to facilitate virus shedding or ion channel proteins that prime
viral uncoating. Recently, it was shown that some classical
naked viruses, like hepatitis A virus, could be enveloped as
well.
Virion surﬁng: directional movement of virions within the cell
plasma membrane, i.e. on the cell surface or cell projections
like ﬁlipodia, towards the viral entry sites
Virus fusion: membrane mixing of the lipid bilayer of
enveloped viruses with a host cell lipid bilayer, i.e. either the
plasma membrane or the endosomal membrane, resulting in
the release of viral nucleocapsids into the cytoplasm.
Uncoating: disassembly of the viral capsid to release the viral
genome into the cytosol or nucleus of a host cell. Large DNA
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assembly of the capsid.
PDZ-domain) and the so called WW-domains which carry two
ryptophan residues as signature (Tompa et al., 2014). Notably,
iruses and other pathogens often make use of these and other
eptide motifs to hijack cellular pathways during their life cycle
ncluding virus entry (Davey et al., 2011; Hagai et al., 2014).
While transcriptomics can reveal long-term alterations of the
ellular state, virus entry usually occurs within minutes and
ypically relies on rapid changes of protein conformation, localiza-
ion, interactions and post-translational modiﬁcations (PTM). Thus
tudying the proteome state, preferentially in a time-resolved man-
er, is ideally suited for understanding the mechanisms of virus
ntry.
Proteomics has already led to the characterization of global
ellular alterations induced by virus infection. For instance, virusch 218 (2016) 25–39 27
induced changes in the protein composition of subcellular HCV
replication compartments revealed several host replication and
assembly factors (Huang et al., 2007; Mannova et al., 2006; Paul
et al., 2013; Yi et al., 2006; Yi et al., 2011). Interaction proteomics
at a large scale was moreover performed for all 18 HIV-1 proteins
outside of the context of HIV-1 infection and revealed impor-
tant virus manipulations of cellular pathways (Jager et al., 2012).
Another global interaction proteomics study revealed host pro-
tein interactions of viral immune modulating proteins uncovering
viral immune evasion strategies (Pichlmair et al., 2012). Although
in principle possible, global interaction proteomics during virus
attachment and entry has not yet been extensively pursued. As
virus entry is the process in the viral life cycle, which can most eas-
ily be synchronized by inhibitors or temperature shifts, we  believe
that proteomic analyses can close many gaps of knowledge in
virus entry research. Below we discuss successful applications of
proteomics to understand virus uptake and highlight future per-
spectives.
The various entry routes of viruses have been extensively
reviewed (Grove and Marsh, 2011; Mercer et al., 2010; Amara and
Mercer, 2015). Similarly, we  refer the reader elsewhere for methods
to deﬁne protein interactions other than MS based proteomics, i.e.,
native PAGE, yeast two  hybrid, protein microarrays, ﬂuorescence
resonance energy transfer, surface plasmon resonance, structure-
based approaches and phage display (Ngounou Wetie et al., 2014).
Here, we focus on the PPIs and PTMs that mediate virus uptake and
on past and present MS  proteomics based techniques to study virus
invasion.
2. Classical biochemical approaches for discovery of virus
receptors
To gain access to a susceptible host cell the vast majority of
viruses interacts with proteinacious receptors on the cell surface.
Consequently, biochemical protein-based approaches successfully
discovered virus receptors in the past (Table 1). Typically, these
approaches build on virus overlay protein blot assays (VOPBA).
VOPBA relies on probing of cell lysates or cell membrane extracts,
separated by gel electrophoresis and transferred onto nitrocellu-
lose membranes, with virus particles (Boyle et al., 1987). Virus
bound proteins are in this case either detected by radiolabelling of
the virus or by speciﬁc antibodies against the virus glycoproteins. In
both cases MS  ﬁngerprinting of a corresponding polyacrylamide gel
band identiﬁes the putative receptor. A prime example for VOPBA
approaches is the identiﬁcation of alpha-dystroglycan as receptor
for lymphocytic choriomenigitis virus (Cao et al., 1998). The VOPBA
qualitative proteomics approach has the advantage that the protein
is left intact until the last step of identiﬁcation and thus informa-
tion on the molecular weight and posttranslational modiﬁcations
like glycosylation is available. However, it suffers from low sensitiv-
ity, as retrieval of proteins or peptides from polyacrylamide gels is
typically low. Moreover interactions could be lost under denaturing
conditions.
An alternative to VOPBA-based receptor identiﬁcation is the
afﬁnity puriﬁcation (AP) of virus glycoprotein – receptor com-
plexes. This method overcomes the caveat of protein denaturation
and analyzes interactions in their native state. For instance, Ig-
fusion proteins of truncated soluble viral glycoproteins were
successfully used to co-purify the New World arenavirus receptor
transferrin receptor 1 (Radoshitzky et al., 2007). Other examples for
qualitative interaction proteomics are the identiﬁcation of recep-
tors for Nipah virus (ephrin B2), KSHV (ephrin A2) and SARS
(angiotensin-converting enzyme 2) (Hahn et al., 2012; Li et al.,
2003; Negrete et al., 2005). Here, glycoprotein−Fc fusion proteins
served as baits for AP of the receptor post cell lysis. In a third
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Table 1
Examples of virus receptors identiﬁed by protein-based approaches.
Virus Baltimore class Family Receptors identiﬁed by
protein-based approaches
Receptor identiﬁcation
strategy
Reference
Varizella zoster virus (VZV) 1 Herpesviridae Insulin-degrading enzyme AP, MS Li et al. (2006)
Karposi  sarcoma herpesvirus (KSHV) 1 Herpesviridae Ephrin A2 AP, MS Hahn et al. (2012)
Hepatitis C virus 4 Flaviviridae Scavenger receptor class B type
I
AP, biochemical assays Scarselli et al. (2002)
Japanese encephalitis virus (JEV) 4 Flaviviridae Heat shock protein 70 VOPBA, MS Das et al. (2009)
Severe acute respiratory syndrome
virus (SARS)
4 Coronaviridae Angiotensin-converting
enzyme 2
AP, MS Li et al. (2003)
Mapucho, Guanarito, Junin and Sabia
virus
5 Arenaviridae Transferrin receptor 1 AP, MS Radoshitzky et al. (2007)
Henipahvirus 5 Paramyxoviridae Nephrin B2 AP, MS Negrete et al. (2005)
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Hepatitis B virus, hepatitis D virus
(HBV, HDV)
7 Hepadnavirida
pproach, Yan et al. used biotinylated receptor binding peptides
erived from the hepatitis B virus (HBV) glycoprotein, equipped
hem with photoactive amino acids and tandem afﬁnity captured
he HBV and hepatitis delta virus (HDV) receptor sodium tauro-
holate cotransporting polypeptide (Yan et al., 2012). Generally,
iotinylation of surface proteins prior to AP or amine-reactive
rosslinking are strategies to increase speciﬁcity of the AP and
elp avoid detection of biologically irrelevant interactions after
ell lysis. A reﬁnement of both methods is the use of biotinylated
igands equipped with hydrazine groups for crosslinking of cell sur-
ace proteins glycans. To this end, a trifunctional reagent for ligand
erivatization, termed TRICEPS, has been developed by Frei et al.
2012). Critical negative controls further include, non-susceptible
ell lines, which do not bind the virus, and glycoprotein mutants or
eptide variants, which are deﬁcient for receptor binding. In prin-
iple, MS  ﬁngerprinting of the puriﬁed proteins is the sole method
o unambiguously identify the prey after AP. It should however be
oted that analysis of the prey with respect to its sensitivity to gly-
osidases, proteases, heparinases and lipid raft altering agents can
ead to an educated guess, which upon further validation might
dentify a virus receptor. A prominent example is the identiﬁca-
ion of scavenger receptor class B type I for HCV (Scarselli et al.,
002). Similar to VOPBA approaches, receptor identiﬁcation after
P relied on qualitative proteomics in the past, i.e. gel puriﬁcation
f the co- precipitated proteins, followed by MS  ﬁngerprinting of
 deﬁned gel band. Such interaction proteomics approaches typi-
ally require a truncated and epitope tagged virus glycoprotein for
fﬁcient afﬁnity enrichment (AE) of cellular receptors. High afﬁn-
ty antibodies against the viral glycoprotein may  supersede epitope
agging of the bait.
Both VOPBA-based and AP-based interaction proteomics are
ell suited for the identiﬁcation of primary receptor interactions.
owever, interactions with late receptors, which require a con-
ormational change of the glycoprotein and are more difﬁcult to
ynchronize, cannot be captured easily with these techniques. Also
irus-triggered secondary PPIs are not resolved by these classi-
al methods. The development of shotgun proteomics techniques
escribed below thus presents a major breakthrough, which holds
he promise of detecting higher order, reduced afﬁnity and even
ransient virus receptor interactions.
. Quantitative interaction proteomics (interaction
ystems virology)
In the past decade, the development of quantitative shot-
un proteomics techniques revolutionized the protein interactions
eld. In contrast to previous qualitative approaches, shotgun tech-
iques avoid extensive puriﬁcation from gels and instead analyze
 complex mixture of proteins, thereby tremendously increasingalpha-dystroglycan VOPBA, MS Cao et al. (1998)
sodium taurocholate
cotransporting polypeptide
VOPBA, MS Yan et al. (2012)
sensitivity and throughput. Technological development of high per-
formance liquid chromatography (LC) and ultra-high resolution
ion trap MS  together reduced measurement time, increased pep-
tide sensitivity and measurement reproducibility and thus made
shotgun techniques possible. Moreover, mass accuracy of new gen-
eration ion trap mass spectrometers increased up to 0.001 Da,
guaranteeing high conﬁdence peptide identiﬁcation and analysis
of posttranslational modiﬁcations (PTMs). LC-MS thus emerged as
prime in depth proteomics method leaving behind alternative tech-
niques like two-dimensional gel electrophoresis, low-resolution
MALDI and protein arrays (Mann and Kelleher, 2008). Shortly, in
shotgun interaction proteomics afﬁnity enriched protein mixtures
are as a whole digested to peptides and analyzed by LC–MS. To
separate the speciﬁc binding partners from the excess of back-
ground proteins, speciﬁc and control puriﬁcations are directly
compared (Vermeulen et al., 2008). This is achieved either by sta-
ble isotope labeling of amino acids in culture (SILAC) or by the
more recent computational based label-free quantiﬁcation meth-
ods (LFQ) described in the subsequent paragraph. Most recent
techniques use one-step AE protocols, which preserve weak and
transient interactions (see below for details). Fig. 1 highlights the
milestones in the development of MS-  based proteomics techniques
and Box 2 describes common proteomics terms. While quantitative
shotgun proteomics has been used in a variety of ﬁelds including
signal transduction, cell adhesion and even viral immune modu-
lation, we are just starting to appreciate its power for the study
of the viral replication cycle and in particular virus entry (Kruger
et al., 2008; Pichlmair et al., 2012; Weekes et al., 2014; Zanivan
et al., 2013).
3.1. SILAC versus label-free methods
MS  based methods are commonly used to identify and quan-
tify proteins, to proﬁle protein-interactions or whole proteomes.
Therefore, proteins are isolated and proteolytically digested, the
resulting peptides are separated via LC, and then analyzed by tan-
dem mass spectrometry (MS/MS) (bottom-up approach or shotgun
proteomics) (Vermeulen et al., 2008). Alternatively a top-down
approach can be used, where the protein is fragmented during the
mass spectrometric analysis (Boeri Erba, 2014). For quantitative
proteomics, most often bottom-up high resolution MS  tech-
niques are used in combination with either labeling or label-free
methods:
A powerful and the most commonly used label-based method
for the quantiﬁcation of proteins is SILAC (Ong et al., 2002). In
short, an isotope label is metabolically incorporated into peptides
and proteins of a cell. Typically, essential amino acids with heavy
isotopes (e.g., 15N, 13C) are fed to cells over several passages until
nearly all unlabeled amino acids are replaced. As the physicochem-
G. Gerold et al. / Virus Research 218 (2016) 25–39 29
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nd  follow up analysis (D) are indicated.
cal properties of light and heavy amino acids are nearly identical,
ells labeled with the isotopic analogs behave similar or even iden-
ical to unlabeled cells. Based on the isotope label SILAC allows the
irect comparison of two cell populations (heavy and light) from
wo distinct experimental conditions; for instance, from cells with
urface-bound virus or cells without bound virus (Gerold et al.,
015). Prior to proteomic analysis, i.e., whole cell lysate analysis
r AP of protein complexes, the differently labeled samples are
ixed. This is advantageous as all samples are processed equally
xcluding sample handling biases. Proteins are then digested, pep-
ides reduced and alkylated, separated by LC and analyzed by MS.
eptides derived from heavy or light cells are subsequently differ-
ntiated by their characteristic mass offset. Relative abundances
f proteins in each sample are calculated based on the heavy and
ight signal intensities in the same spectrum. Typically, SILAC is
sed for relative quantiﬁcation of protein levels under two differ-
nt cellular conditions. Of note, medium labeled amino acids are
dditionally available and allow expanding a SILAC experiment to
hree cellular conditions (Hilger and Mann, 2012). The high accu-
acy of SILAC typically requires analysis of only two  experimental
eplicates. In addition, two replicates of a label swap experimental
ondition allow assessing label-speciﬁc effects. Thus, a typical dual
ILAC experiment starts with eight experimental samples mixed
nto four SILAC pairs. Those are duplicates of the forward label pair
light-condition 1; heavy-condition 2) and duplicates of the reverse
abel pair (light-condition 2; heavy-condition 1). Fig. 3A depicts the
ILAC workﬂow.
SILAC followed by LC-MS/MS can answer various questions in
irology. For example, it can be used to compare the proteome ofe labeling (A) or label-free (B) technologies. Consecutive quality control steps (C)
uninfected to that of virus infected cells (e.g., Zhang et al., 2013).
Also cells at different time points post infection can be analyzed to
understand how viruses alter host cell protein expression (Weekes
et al., 2014). For instance, Berard et al. performed a temporal quan-
tiﬁcation of cells infected with herpes simplex virus type 1 (HSV1)
and by this showed how HSV1 modulates the metabolic function of
the host cell (Berard et al., 2015). Beside this, SILAC followed by LC-
MS/MS  can also be used to identify cellular targets of viral enzymes,
as it has been done for the identiﬁcation of the HCV protease NS3-4A
targets: by comparing whole proteomes from hepatoma cells with
and without the NS3-4A protease, Morikawa et al. discovered that
‘probable glutathione peroxidase 8’ is cleaved by the viral protease
(Morikawa et al., 2014). SILAC is also suitable to analyze how viruses
alter the proteome of distinct cellular compartments. For instance,
Xie et al. deﬁned the modiﬁcation of lipid raft composition in HBV
infection (Xie et al., 2012).
In combination with AP of a protein of interest, SILAC followed
by LC–MS/MS can also discover protein-interactions and dynamic
changes in interaction complexes (reviewed e.g., in (Gingras et al.,
2007; Trinkle-Mulcahy, 2012)). High-throughput AP-MS has led to
important ﬁndings regarding virus entry, for instance the identiﬁ-
cation of receptors or receptor-complexes. A successful example is
the AP-MS analysis of the HCV receptor CD81, which revealed HRas
as a CD81-binding partner and signaling molecule needed for HCV
entry (Zona et al., 2013).A clear beneﬁt of SILAC is its high reproducibility, robustness and
relatively easy execution. SILAC is applicable to most cell culture
cells and sample conditions. Even SILAC mice have been developed
in the past for ex vivo proteomics analyses (Zanivan et al., 2012).
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Box 2: Deﬁnitions and abbreviations in mass spectrom-
etry based proteomics.
Proteome: entity of proteins expressed at a given cellular
state or in a given tissue. The term was coined in analogy to
‘genome’ in 1996.
MS:  mass spectrometry.
ESI: electrospray ionization; ionization technique based on
spraying of a sample solution into a strong electric ﬁeld.
MALDI: matrix-assisted laser desorption/ionization; ionization
technique based on mixing of samples with a matrix, which
absorbs ultraviolet light and converts it to heat energy leading
to sample vaporization.
Bottom up proteomics: identiﬁcation of proteins based on
MS  peptide ﬁngerprints after digestion of a protein into pep-
tides using a sequence-speciﬁc enzyme such as trypsin.
Top down  proteomics: MS  analysis of entire proteins.
Shotgun proteomics: bottom-up proteomics technique to
identify proteins in a complex mixture. Proteins are digested
to peptides, peptides separated by liquid chromatography and
then identiﬁed by tandem MS.
Quantitative proteomics: shotgun proteomics with the
additional dimension of measuring the quantity of a protein in
a complex sample. Relative quantities in two or more samples
are determined either by SILAC or LFQ (see below). Abso-
lute quantiﬁcation can be achieved using spike in standards
or a proteomics ruler (see paragraph on protein complex stoi-
chiometry).
Interaction proteomics: unbiased identiﬁcation of
protein–protein interactions by afﬁnity enrichment followed
by MS.
SILAC: stable isotope labeling by amino acids in cell culture;
ﬁrst quantitative method for the comparison of cellular protein
amounts in two  to three different cellular states. SILAC is based
on the isotope labeling of cellular proteins by feeding cells with
heavy isotope amino acids (e.g. N-15 and C-13 labeled arginine
and lysine).
Label-free quantiﬁcation (LFQ): quantitative proteomics
technique based on either signal intensity measurement or
spectral counting followed by computational matching of pep-
tides from multiple samples and signal normalization.
PPI: protein-protein interactions.
PTM: posttranslational modiﬁcation. Common protein mod-
iﬁcations include among others phosphorylation, lipidation,
glycosylation, methylation, acetylation, ubiquitinylation and
SUMOylation.
AP-MS: afﬁnity puriﬁcation of proteins using antibodies
against endogenous epitopes or epitope tags followed by mass
spectrometric identiﬁcation or quantiﬁcation of the bound pro-
teins.
AE-MS: afﬁnity enrichment of proteins using fast single step
methods, which preserve transient and low afﬁnity inter-
actions, followed by mass spectrometric identiﬁcation or
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as they occur when virus receptor complexes change upon virusquantiﬁcation of bound proteins.
aveats of SILAC are the limited sample number of maximum three
nd the additional labeling step requiring culturing of cells for two
o three weeks prior to analysis. Thus some primary human cells,
hich rapidly dedifferentiate ex vivo, are not suited for SILAC. Sim-
larly, clinical samples cannot be labeled and are thus not amenable
o SILAC analysis.
Increasingly popular alternatives to SILAC are LFQ methods.
hese can determine the relative or absolute abundance of a
rotein in complex samples. The ﬁrst semi-quantitative label-
ree method developed, which has since then been continuously
eﬁned, is based on the measurement of MS/MS  peptide intensities
Bondarenko et al., 2002). To this end, peak areas of all identiﬁed
eptides from one protein are summed up and normalized to one
r several proteins with constant concentration or even to all iden-rch 218 (2016) 25–39
tiﬁed proteins in the sample. Bondarenko et al. showed that there
is a linear correlation of the abundance of a protein and its total
reconstructed peak area. An alternative semi-quantitative method
used is spectral sampling (Liu et al., 2004). It was  shown that highly
abundant proteins are sampled more frequently by LC–MS/MS and
that the spectral copy number obtained increases linearly with the
concentration of a protein. Accordingly, the number of MS/MS  spec-
tra gained for one protein can be counted and compared between
different samples measured using the same experimental condi-
tions. Several computational approaches to predict speciﬁc protein
interactions in label-free datasets have been developed, among
them Signiﬁcance Analysis of INTeractome (SAINT) and Mass spec-
trometry interaction STatistics (MiST) (Choi et al., 2011; Jager et al.,
2012). These tools compute interaction probabilities based on spec-
tral counts of all interactions that a prey-bait pair is involved in
or based on abundance, reproducibility and speciﬁcity of a prey-
bait pair, respectively. Recent developments in MS  technology and
analysis algorithms now allow highly sensitive, efﬁcient and robust
intensity-based label-free protein quantiﬁcation (reviewed e.g., in
(Nahnsen et al., 2013)). For this, samples are processed in parallel
and not mixed, as in SILAC. Thus, an unlimited number of samples
can be compared. Normalization is achieved post LC–MS/MS analy-
sis by comparing all peptide signals from all MS  runs and assuming
that most protein signals remain unaltered in the different sam-
ple conditions. Thus, no external standards are needed (Cox et al.,
2014). However, acquisition of accurate datasets requires the anal-
ysis of at least three, typically four, biological replicates (Fig. 3B).
MS combined with LFQ algorithms is suitable for virological
research and has been used e.g., to show that subsets of den-
dritic cells (DCs) differ in their ability to sense single stranded
RNA (ssRNA) viruses (Luber et al., 2010). Brieﬂy, Luber at al. com-
pared the whole cell proteome of DC subsets by high-resolution
MS  combined with LFQ. They found, that DC subsets differently
express proteins involved in pattern recognition pathways and that
this correlates with their ability to sense ssRNA viruses, such as
Sendai virus and inﬂuenza A virus. Label- free methods also allow
the analysis of protein complexes. Importantly, extensive puriﬁ-
cation of complexes prior to LC–MS/MS is no longer necessary for
LFQ. Instead one AE step is sufﬁcient for precise complex proﬁling,
when controls are designed appropriately (Keilhauer et al., 2015).
False positive interaction partners, which are proteins unspeciﬁ-
cally binding to the afﬁnity resin, are computationally eliminated
by comparing datasets to those of a control AE sample from cells
without bait. Fig. 3B outlines the here described LFQ workﬂow.
When compared to label-based methods, LFQ techniques have
several advantages: nearly all kinds of samples can be measured,
including clinical material and primary cells; sample number is
unlimited; no special sample processing steps are needed; slight
differences in sample preparation and measurement between the
different samples are tolerated.
Both, labeling and label-free quantiﬁcation methods identify
and quantify proteins with high conﬁdence and lead to highly accu-
rate results. Each step of the proteomics workﬂow can be quality
controlled, e.g., by immunoblotting, computational analysis of pep-
tide intensity distributions, and clustering analysis of biological
replicate datasets (Fig. 3C). To study virus entry both SILAC and
LFQ are valuable tools. LFQ is ideally suited to study steady state
virus receptor interactions. To this end, virus receptor-complexes
are puriﬁed from cells expressing the receptor and cells lacking
the receptor. Comparison of both datasets then allows to deﬁne
receptor interacting proteins in a given cell line. SILAC on the other
hand can sensitively distinguish low degree quantitative changes,binding. Brieﬂy, heavy labeled cells are incubated with virus and
light cells are left untreated (forward label); and vice versa (reverse
label). After sample mixing, AP of receptor complexes and LC–MS
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nalysis, changes in interaction strength of each protein in the
eceptor complex can be determined. Importantly, the untreated
ontrol should ideally contain all extracellular components as the
irus sample, i.e. the ideal control is incubation with virus, which
ad been neutralized by blocking antibodies, or incubation with a
mock” virus preparation if such antibodies are not available. Using
ILAC, we recently identiﬁed transient, virus-triggered interactions
f the HCV receptor CD81. Among the 26 dynamic CD81 interac-
ors we identiﬁed serum response factor binding protein 1 as a
ost factor aiding HCV entry (Gerold et al., 2015). Of note, simi-
ar studies will soon be possible with advanced LFQ methods. Fig. 3
llustrates how quantitative proteomics can identify steady state
nd dynamic virus-triggered receptor interactions. In summary,
ILAC and LFQ are powerful tools for analyzing virus-host inter-
ctions and global proteomic changes upon virus infection. Due to
he recent improvements in high resolution MS and label-free anal-
sis tools, the highly accurate, cost effective and broadly applicable
FQ methods will soon become the method of choice for proﬁling
roteins, their interactions and whole proteomes.
.2. Steady state virus receptor interactions
Steady state interactions of cellular proteins, which preexist
efore virus attachment, can be crucial for virus infection. This
as been shown in the past mainly by biochemical assays. For
nstance, the interaction of moesin and CD46, which is needed
or measles virus entry, was demonstrated by AP followed by
mmunoblot analysis (Schneider-Schaulies et al., 1995). Since MS-
ased proteomics became the method of choice to analyze protein
nteractions, several studies used mostly non-quantitative pro-
eomic techniques to characterize interactions of virus receptors.
or example Chakraborty et al. (2012) analyzed immuoprecipitates
f the Kaposiı´s sarcoma- associated herpesvirus (KSHV) recep-
or and lipid raft protein integrin 31 via SDS-PAGE and MS
f selected gel bands. They identiﬁed the association of integrin
31 with several proteins, including EphA2. The identiﬁed asso-
iations were enriched in lipid rafts of KSHV infected human
ermal microvascular endothelial cells, compared to uninfected
ells. With virological assays Chakraborty et al. then showed that
his enrichment is important for effective KSHV infection, espe-
ially for macropinocytosis and trafﬁcking of the virus.
Also quantitative MS-based techniques in combination with tra-
itional virological assays can be used to decipher the role of steady
tate protein interactions in different steps of the viral life cycle. An
xcellent example is the identiﬁcation of a PPI network consisting of
he HCV receptors CD81 and Claudin1 and the membrane proteins
Ras, Rap2B and ITGB1, which are required for efﬁcient entry of the
irus into hepatocytes (Zona et al., 2013). The authors identiﬁed
he HCV receptor network by SILAC of human hepatoma cells with
nd without CD81 receptor expression. The role of the identiﬁed
roteins in the HCV entry process was then studied by virologi-
al assays in conjunction with RNA silencing and small molecule
nhibitors.
Using a similar workﬂow, host restriction factors can likewise be
iscovered. One example is the association of EWI-2 and -actinin-
 in T-cells. Gordon-Alonso et al. (2012) identiﬁed the complex by
nalyzing EWI-2 co-precipitated proteins via non-quantitative MS,
nd later on showed that the complex negatively regulates HIV 1
ntry. Similarly, the cleavage product of EWI-2, EWI-2wint, has
een shown to interact with the HCV receptor CD81 and by this
nhibit HCV entry (Rocha-Perugini et al., 2008). As EWI-2wint is
ot expressed in the target cells of HCV, which are hepatic cells,
his interaction could contribute to the viral cell tropism.
In summary, the analysis of steady state virus receptor interac-
ions can reveal protein complexes critical for virus uptake and in
ome cases help understand host and tissue tropism.ch 218 (2016) 25–39 31
3.3. Virus-triggered receptor interactions
Upon binding of viruses to their receptors, additional secondary
PPIs are triggered, most of which lead to virus entry. These inter-
actions have at least ﬁve distinct functions depending on the
virus entry strategy. First, binding of the multivalent virus parti-
cle to the cell surface can induce receptor clustering, as has been
shown for phleboviruses and inﬂuenza A viruses (Eierhoff et al.,
2010; Lozach et al., 2011). While it is unclear whether inﬂuenza
A virus triggered clustering of sialylated receptor tyrosine kinases
like EGFR and c-Met is required for endocytic virus uptake, phle-
bovirus induced clustering of DC-SIGN seems to trigger signaling
needed for uptake. Other viruses, which have been suggested to
induce receptor clustering, include coxsackievirus B and Lassa virus
(Coyne and Bergelson, 2006; Moraz et al., 2013). HIV-1 entry also
relies on clustering of its CD4 and CXCR4 receptors on the plasma
membrane. Speciﬁcally, the HIV gp120 glycoprotein signals for
recruitment of actin adaptor proteins ﬁlamin and debrin, which
regulate actin rich cap formation at the virus entry site (Gordon-
Alonso et al., 2013; Jimenez-Baranda et al., 2007). Notably, actin
depolymerization is induced at later stages of the HIV entry pro-
cess, highlighting that actin remodeling during virus entry is highly
dynamic and tightly regulated. While proteomes of detergent resis-
tant membrane microdomains have been determined in naïve and
virus replicating cells resulting in the identiﬁcation of more than
200 proteins (Foster et al., 2003; Xie et al., 2012), few quantitative
proteomics dataset are currently available for receptor platforms
upon virus binding to the cell surface. For the HCV receptor CD81,
we recently described the virus triggered receptor interactome
and identiﬁed cytoskeleton regulators, cell junction proteins and
a clathrin adaptor protein (Gerold et al., 2015).
Second, viruses can induce signaling leading to actin cortex dis-
assembly. This is particularly important for viruses, which directly
penetrate the cell at the plasma membrane and need to overcome
the physical barrier of the actin cortex. Viruses entering by endo-
cytosis might similarly require local actin cortex disassembly at
the site of the incoming vesicle. Although the concept that the
cortex can prevent or delay transit of viruses has already been sug-
gested by Marsh and colleagues in 1997 (Marsh and Bron, 1997),
only few studies address virus induced actin cortex remodeling.
A well-studied example is HIV, which upon Env binding to the
CXCR4 coreceptor induces Galphai signaling and subsequent coﬁlin
activation leading to actin depolymerization thereby facilitating
nuclear translocation of HIV particles (Yoder et al., 2008). Of note,
not only actin cortex but also actin stress ﬁber disruption can aid
virus entry. For instance cytomegaloviruses binding to EGFR and
integrin alphaVbeta3, induces coﬁlin dependent actin stress ﬁber
disruption thereby facilitating nuclear translocation of incoming
virions (Wang et al., 2005).
Third, viruses, which use multiple receptors for entry, can
induce their lateral translocation along the plasma membrane
towards the site of endocytic uptake. A prominent example of
such surﬁng is coxsackievirus B, which after binding to the api-
cal decay-accelerating factor (DAF) on epithelial cells induces Abl
kinase signaling and subsequent Rac-dependent actin reorganiza-
tion. This leads to the lateral translocation of the coxsackievirus
B—DAF complex to tight junctions, where the secondary receptor
coxsackievirus-adenovirus receptor (CAR) is localized. After CAR
engagement coxsackievirus B is endocytosed. This endocytosis is
also triggered by PPIs as initial DAF binding additionally induces Fyn
kinase, which phosphorylates caveolin thereby facilitating uptake
(Coyne and Bergelson, 2006). HCV seems to use a similar multi-
step strategy to enter after initial binding to the basolateral side of
hepatocytes, where the receptors SR-BI and CD81 reside. Through
a yet insufﬁciently described mechanism HCV also triggers lat-
eral translocation of the CD81–virus complex to tight junctions,
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here the two additional entry factors CLDN1 and OCLN reside and
ndocytosis occurs (Brazzoli et al., 2008). Receptor tyrosine kinases
ike EGFR are thought to provide the trigger for lateral membrane
ranslocation through HRas signaling (Zona et al., 2013). Moreover,
urﬁng of HCV and retroviruses on ﬁlopodia has been observed and
s governed by PPI with the actin cell cortex (Coller et al., 2009;
ehmann et al., 2005).
Fourth, viruses, which enter through endocytic routes, can
nduce endocytic uptake mechanisms including clathrin-mediated,
aveolin-dependent, macropinocytic or alternative uptake routes
ike the clathrin-independent carriers in parvovirus entry
Nonnenmacher and Weber, 2011). On the one hand, some viruses
ike human rhinovirus 2 and phleboviruses hijack endogenous
onstitutive receptor recycling pathways. After endocytosis phle-
oviruses, which hijack DC-SIGN for cell entry into DCs, however
issociate from the receptor in the early endosome thereby avoid-
ng antigen processing and presentation (Lozach et al., 2011). On
he other hand, viruses can actively trigger their endocytosis like
nﬂuenza A virus. After interaction of inﬂuenza virions with sialy-
ated membrane receptors, the clathrin adaptor Epsin-1 is recruited
n a ubiquitin-dependent manner towards the receptor complex
nd induces clathrin-coated pits (Chen and Zhuang, 2008). PI3K
ctivation was independently reported to be required for inﬂuenza
ptake, thus more than one signaling pathway might coordinate
ptake of a virus. This is in line with reports, showing that inﬂuenza
irus can utilize more than one endocytosis pathway to gain access
o host cells (Rust et al., 2004; de Vries et al., 2011). Larger viruses
ike poxviruses enter by macropinocytosis and actively induce this
ptake pathway through Rac-1 and p21-activated kinase 1 (Pak-1)
ependent actin remodeling (Mercer and Helenius, 2008). Forma-
ion of plasma membrane protrusions is however not speciﬁc to
oxviruses, but occurs also during entry of herpes viruses, papillo-
aviruses and ﬂaviviruses (Clement et al., 2006; Coller et al., 2009;
mith et al., 2008).
Lastly, several viruses need to interact with host enzymes to
rigger their uptake. A prominent example is ebola virus, which
equires proteolytic processing of its envelope glycoprotein GP1 by
athepsin B and L to render it fusion competent (Chandran et al.,
005). Similarly coronavirus relies on cathepsin cleavage of its spike
rotein to permit fusion (Simmons et al., 2005). In addition to lyso-
omal enzymes, cell surface proteases can prime VAPs for fusion,
ike shown for some inﬂuenza A virus strains and SARS coronavirus
Bertram et al., 2010; Bertram et al., 2011). Host protein disulﬁde
somerases similarly regulate entry by catalyzing disulﬁde shuf-
ing in viral envelope proteins, as shown for dengue virus, HIV-1
nd Newcastle disease virus (Jain et al., 2008; Ryser et al., 1994;
tantchev et al., 2012; Vega-Almeida et al., 2013). Of note, high
esolution proteomics can not only reveal transient interactions of
AP with enzymes, but also has the potential to identify proteolytic
leavage sites and redox modiﬁcations in VAPs.
It is conceivable that virus induced protein interactions during
ntry not only serve to promote the virus uptake pathway, but can
lso help cloak viruses and lead to immune evasion. For instance,
he HIV capsid recruits two cofactors, cleavage and polyadenyla-
ion speciﬁcity factor subunit 6 (CPSF6) and cyclophilins (Nup358
nd CypA), thereby preventing antiviral IFN responses (Rasaiyaah
t al., 2013). More complex viruses can further express viral gene
roducts on the infected cell surface, which then bind receptors
n bystander cells and modulate immunity. For instance, HCMV
rotein pUL11 binds to CD45 on T cells thereby reducing T cell
roliferation (Gabaev et al., 2011). While we here focus on the role
f virus - host PPI in entry, it should be noted that quantitative
irus entry proteomics at the same time has the potential to reveal
mmunomodulatory mechanisms. Similarly, PPIs of viral tegument
nd capsid proteins with host proteins occurring after membrane
usion are amenable to quantitative proteomics. We  refer therch 218 (2016) 25–39
reader elsewhere for the detailed description of post-fusion PPIs
coordinating nuclear trafﬁcking (Dohner et al., 2005; Yarbrough
et al., 2014).
Comprehensive proteomics analyses of virus induced PPIs lead-
ing to actin remodeling and endocytic uptake of virions are
lacking to date. However, several studies underline the value of
proteomics to analyze stimulus speciﬁc interactions in cellular
signaling pathways. For instance, the ligand-induced changes of
the two Wnt  signaling pathway members adenomatous polyposis
coli protein (APC) and axin-1 identiﬁed 28 and 18 dynamic inter-
action partners, respectively (Hilger and Mann, 2012). For other
virus life cycle steps, like e.g., CMV  particle assembly, interaction
proteomics uncovered important mechanistic insights (Moorman
et al., 2010). Further, interaction proteomics of viral immunomodu-
latory proteins revealed virus induced alterations in human protein
interaction networks and underlying viral perturbation strategies
(Pichlmair et al., 2012). Similar studies hold the promise of uncov-
ering common and speciﬁc viral strategies to alter and exploit host
cell functions during cell entry.
3.4. PTMs
Post-translational modiﬁcations (PTMs) play two major roles
during virus entry into a host cell. First, virus receptor PTMs can
be critical for the localization to speciﬁc membrane microdomains.
For instance, palmitoylation of the HCV receptor CD81 and its asso-
ciated proteins EWI-2 and EWI-2wint regulate their interaction
with each other and the localization to cholesterol rich mem-
brane domains thereby inﬂuencing HCV entry (Montpellier et al.,
2011; Zhu et al., 2012). Second, viruses rely on cell signaling for
their uptake and such cellular signals are often transmitted via
PTMs like reversible protein phosphorylation. A widespread exam-
ple common to viruses of diverse families including herpesviruses,
papillomaviruses and ﬂaviviruses is the triggering of receptor tyro-
sine kinase signaling (Hahn et al., 2012; Lupberger et al., 2011;
Surviladze et al., 2013; Zheng et al., 2014). In most cases sig-
naling through growth factor receptors regulates actin dynamics
required for virus trafﬁcking into the cell. Some respiratory viruses
however use EGFR signaling to suppress antiviral signaling in the
airway epithelium (Ueki et al., 2013). Other phosphorylation signals
that coordinate virus entry are the Src kinase pathway in HCMV
penetration (Nogalski et al., 2013) and the Lassa virus induced
phosphorylation of its receptor dystroglycan (Moraz et al., 2013).
Certain kinase activities can be a hallmark of a speciﬁc uptake path-
way, as for instance PAK-1 for macropinocytic virus entry (Amstutz
et al., 2008). In particular for large DNA viruses not only host pro-
teins are phosphorylated early during virus infection, but also viral
gene products. For instance, herpes simplex virus type 1 (HSV-1)
protein pUL46 is heavily phosphorylated six hours post infection
and interacts with several viral and host kinases as determined by
quantitative interaction proteomics (Lin et al., 2013).
Apart from protein phosphorylation, other PTMs like ubiq-
uitination are thought to regulate virus uptake, but are poorly
characterized. Ubiquitination of viral proteins seems to induce viral
uncoating in at least two instances. Inﬂuenza A virus M1 protein is
ubiquitinated by the E3 ligase Itch and this is a prerequisite for
endosomal escape (Su et al., 2013). Vaccinia virus on the other
hand uses ubiquitinated incoming viral core proteins to trigger pro-
teasomal degradation of its protein coat (Mercer et al., 2012). All
aforementioned studies, except for the HSV-1 study, demonstrate
PTMs of receptors, downstream signaling molecules or viral pro-
teins by immunoblotting, thus requiring prior knowledge of the
signaling pathways.
In contrast, MS-based identiﬁcation and quantiﬁcation of PTMs
upon virus binding to a host cell is completely unbiased and thus
broadly applicable. Another advantage over previous immunoblot
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ased methods is the global and quantitative measurement of
TMs by MS in conjunction with the ability to pinpoint the mod-
ﬁed amino acid. Clearly, high read depth is required for PTM
roteomics as the search space for the peptides explodes when
aking into account all possible peptide PTMs and all of their
ombinations. Still successful large-scale measurements of pro-
ein phosphorylation (Ficarro et al., 2002; Olsen et al., 2006),
-glycosylation (Kaji et al., 2007), lysine methylation (Ong et al.,
004) or acetylation (Kim et al., 2006), ubiquitination (Peng et al.,
003) and sumoylation (Andersen et al., 2009; Impens et al.,
014) have been achieved. To overcome the caveat of low abun-
ance of modiﬁed peptides, enrichment methods for instance using
nti-phosphotyrosine antibodies are available. Importantly, when
easuring PTMs in interaction proteomics samples, which are of
uch lower complexity than whole cell lysates, PTM identiﬁcation
s facilitated.
For stimuli other than viruses, PTM proteomics has yielded com-
rehensive datasets. For instance, phosphoproteomics of epidermal
rowth factor (EGF) stimulated HeLa cells unraveled 6600 phos-
horylation sites on 2244 proteins, with 14% of the interactions
howing an at least 2-fold modulation by EGF. The majority of
roteins further showed multiple PTM sites with different kinet-
cs highlighting how one protein can integrate numerous signals
Olsen et al., 2006). This and other studies underline the complexity
f receptor signaling. How extensively virus-receptor interactions
lter the phosphoproteome of a host cell, was demonstrated in
 ﬁrst global description for HIV-1 entry (Wojcechowskyj et al.,
013). A total of 239 phosphorylation sites in 175 proteins changed
ust one minute after HIV-1 binding and the study disclosed sev-
ral previously unknown HIV-1 entry factors. It is conceived that
ost viruses will trigger PTM-dependent signaling during their
ntry process and this is either critical for cell penetration or for
odulating cellular immunity. Recent developments in PTM pro-
eomics now allow the global mapping of virus induced changes in
ost proteome PTMs and can thereby disclose signaling pathways
ctive during cell entry.
.5. Protein complex stoichiometry
The stoichiometric composition of receptor complexes is critical
or membrane microdomain localization, signal coordination and
igand binding. Interaction proteomics can provide information on
he relative abundances of a protein in a complex. Typically prey
rotein abundance in the pull down is corrected for the prey abun-
ance in a control pull down and subsequently normalized to the
ait protein. This approach was used to estimate the stoichiometry
f the YAP and TAZ protein complexes in the human Hippo pathway
Kohli et al., 2014).
Beyond complex stoichiometry measurements, shotgun pro-
eomics now allows to estimate which fraction of a protein is
equestered into a protein complex. Mann and colleagues recently
eveloped a method to estimate protein copy numbers in label-
ree proteomes from whole cells. This “proteomic ruler” technique
etermines the absolute abundance of a protein in a cell, based
n the fact that the total amount of histones, which is deﬁned by
he cell ploidity and genome size, can be used for normalization
f any detected protein in a proteomic dataset of sufﬁcient depth.
he minimum depth of a whole cell proteome to guarantee reli-
ble histone based scaling is 12,000 peptides. This scaling method
s similarly accurate as previous spiked-in protein epitope signa-
ure tags (PrESTs) based methods, which required cell counting and
ell labeling (Wisniewski et al., 2014). Thus, whole cell proteomic
atasets can provide information on total protein copy numbers in
 given cell. Based on this knowledge the receptor complex sto-
chiometry can be estimated by comparing relative abundances
f co-puriﬁed proteins in an AE proteomics dataset. Success-ch 218 (2016) 25–39 33
ful receptor complex stoichiometry calculation has recently been
demonstrated for subcellular fractionation proteomics (Borner
et al., 2014). Thus, shotgun proteomics goes beyond pure identi-
ﬁcation of virus entry receptor complexes, but is also suitable to
estimate complex stoichiometry and degree of sequestration of a
protein into a complex.
4. Modeling of virus entry networks
The era of systems biology and proteomics puts the virologist
into the unique position of drawing a comprehensive picture of all
molecular interactions during virus infection of a host cell. Large
scale genome and transcriptome-based methods for the charac-
terization of virus-host interactions, including mRNA microarrays,
RNA interference and cDNA library screens, led to the discovery of
a multitude of host factors. We  currently lack information on the
physical interconnection of these host factors and thus it is difﬁ-
cult to identify critical players in virus entry pathways. Open access
databases on PPIs like the Search Tool for the Retrieval of Interacting
Genes/Proteins (STRING) integrate public databases like IntAct and
Reactome and can facilitate the mapping of host factors into known
networks (Croft et al., 2014; Orchard et al., 2014; Szklarczyk et al.,
2015). However, many virus host factors do not map to previously
described networks. Also, virus induced changes of cellular PPIs are
not deposited in current databases. Some repositories, however,
curate host-pathogen interactions, e.g., VirHostNet and the HIV-
centric GPSprot site (Fahey et al., 2011; Guirimand et al., 2015).
Importantly, viruses do not play according to the rule, i.e., they
may  induce PPI that do not normally exist in non-infected cells.
For instance, they can change the subcellular localization of a host
factor and thereby connect pathways, which in an uninfected cell
operate independently. Thus, existing databases on host PPI may
have only limited predictive value for infected cells, in particular at
steps of the life cycle that heavily depend on the cell’s machinery
like virus entry. Again this calls for repositories that either special-
ize in or integrate PPI from infected cells.
The above described technological advances now enable rapid
acquisition of large sets of protein interaction data from one-step
AEs. Thus, proteomics is now high throughput compatible and
amenable to systems biology studies (Hosp et al., 2015) providing
the unprecedented chance to globally deﬁne protein–protein net-
works during virus infection. Critical for high conﬁdence network
generation and data deposition is the analysis of a large number of
biological replicates, experimental conditions and controls includ-
ing immunoprecipitates from bait deﬁcient cells. Furthermore,
several laboratories performed control pull-downs under various
experimental conditions and established a “contaminant repos-
itory for AP” (CRAPome) (Mellacheruvu et al., 2013). However,
background binders can critically differ between experimental
setups and thus a universal CRAPome is problematic, making
internal controls more reliable (Keilhauer et al., 2015). Clearly,
newly acquired datasets on virus infection interactomes should
be integrated into established host protein–protein networks.
Currently, the above mentioned VirHostNet is probably the most
comprehensive database for virus-host interactions, which directly
links interaction partners to UniProt (Guirimand et al., 2015). As
many pathogens share mechanisms for exploiting host cells, a
central database for host-pathogen interactions, multiplexing
datasets for viruses, bacteria, fungi and parasites would allow the
rapid identiﬁcation of critical nodes and putative broad spectrum
drug targets. Clearly, publically available databases should reliably
catalogue virus-host interactions and make these easily accessible
to the virologist community through user-friendly web  interfaces.
Ultimately, genomics and proteomics techniques provide essen-
tial complementary datasets, which can be integrated to reveal a
34 G. Gerold et al. / Virus Resea
Box 3: Network term deﬁnitions.
Node: component of a network, e.g., a gene or a protein.
Hub: node, which is highly connected and therefore a point of
control of a speciﬁc subnetwork.
Bottleneck: node, which connects subnetworks and thus crit-
ically restricts information ﬂow.
Edge: connection of two nodes in a network, e.g., representing
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ma physical interaction of two proteins.
ost complete picture of molecular events during virus infection.
unctional genomics screens can weigh the importance of a host
actor in an interaction network and reveal redundant pathways.
nnotation clusters can highlight the enrichment of certain cel-
ular processes, molecular functions or protein domains (Mercer
t al., 2012). Novel open access bioinformatics solutions building
n available resources like STRING and DAVID can help harmo-
izing available datasets. Scripting and visualization environments
ike Cytoscape, R and Bioconductor, which were previously devel-
ped for transcriptomics and genomics data integration, are also
uitable for pathway mapping of proteomics data (Cline et al.,
007; Gentleman et al., 2004). Proteomics-speciﬁc and publically
vailable programs like Perseus provide an additional tool for data
nalysis and integration (Cox and Mann, 2012). Meta-analysis of
mics datasets together with sharing of data in a timely manner
ill be critical to successfully model the complexity of virus-host
nteractions in the future (Law et al., 2013).
Such networks will then allow the identiﬁcation of essential
odes, bottlenecks and hubs for selection of optimal drug tar-
ets. Each node in a PPI network represents a protein, while the
dges indicate interactions. Bottlenecks are nodes in a network,
hich critically connect subnetworks and thus restrict informa-
ion ﬂow, like e.g. central kinases in a signaling pathway. Hubs
nstead are highly interlinked and therefore central points of con-
rol, but typically only control one branch of a signaling pathway.
hile bottlenecks are less attractive drug targets as their inhibition
ould shut down complete endogenous pathways, hub inhibition
an lead to an efﬁcient block of infection (Box 3). Furthermore, drug
argeting of pathogen relevant PPIs using small molecule drugs or
eptidomimetics seems an attractive strategy to combat infection
de Chassey et al., 2012a; Law et al., 2013). In particular, targeting
f interfaces between viral and host proteins, holds the promise
f minimal side effects. But even host PPIs, which are triggered
r exploited during virus infection, represent attractive targets.
n contrast to direct acting antivirals, which often lead to rapid
mergence of viral resistance mutations, host proteins and thus
heir interactions represent a high evolutionary barrier (Gerold
nd Pietschmann, 2014; von Hahn et al., 2011). In particular, host
roteases and kinases are attractive drug targets and both protein
lasses can be identiﬁed by advanced interaction proteomics and
TM proteomics, respectively. Taken together, increasing knowl-
dge on interactomes during virus infection and the compilation of
nteractome datasets can spur the development of novel antiviral
herapeutics. The experimental validation of central network hubs,
lso as potential drug targets, is discussed below.
. Hypothesis generation and experimental validation
Protein interaction network analysis allows in the next step to
ypothesize, which biological pathway is critical for virus uptake
nd whether certain proteins are central hubs in the network. The
ypothesis can then be tested by disrupting the function of one
f the interaction partners and studying the resulting phenotype
Fig. 3D). To this end, blocking antibodies have been used, but the
ethod is limited to proteins with accessible extracellular domains.rch 218 (2016) 25–39
Alternatively, small molecule inhibitors, if available, can block the
protein of interest. Due to their microreversibility and rapid mode
of action, such molecular probes have in the past proven indispens-
able to dissect the kinetics of virus-host cell interplay.
The most commonly used strategy to address a protein’s func-
tion was in the past the disruption or reduction of its expression by
RNA interference (RNAi) (Elbashir et al., 2001; Fire et al., 1998).
Here, short RNA molecules sequence-speciﬁcally target comple-
mentary mRNAs and induce their degradation. RNAi has been used
to address the role of protein interactions identiﬁed by MS  in virus
entry (Zona et al., 2013). However, RNAi approaches can have off-
target effects (reviewed e.g., in (Mohr et al., 2014)) and the slow
kinetics of action of two to three days can lead to compensatory
adaptation of cells. This might be the reason why large-scale RNAi
screens performed poorly in studies of virus entry, which operates
at a minute timescale (de Chassey et al., 2012b).
Since 2012, targeted genome editing became possible making
use of a bacterial adaptive antiviral immune mechanism. Clustered
regularly interspaced short palindromic repeats (CRISPR) in combi-
nation with the RNA guided DNA endonuclease CRISPR associated
protein 9 (Cas9) is able to induce speciﬁc DNA double strand breaks
(Gasiunas et al., 2012; Jinek et al., 2012). Therefore, the system
can be used to generate site-speciﬁc modiﬁcations in genomes,
e.g. to knock-out speciﬁc proteins (reviewed e.g. in (Doudna and
Charpentier, 2014)). The CRISPR-Cas9 technology has already been
applied to analyze the function of different proteins in the viral
entry process. For example CRISPR-Cas9 knock-out of PDZD8 veri-
ﬁed its role in HIV-1 and murine leukemia virus infections (Zhang
and Sodroski, 2015). In a different approach, a genome wide lentivi-
ral CRISPR-Cas9 library was developed to screen for cellular factors
essential for entry and cell-to-cell transmission of HCV (Ren et al.,
2015). In this screen, the known HCV entry factors CD81, claudin-1
and occludin were identiﬁed. While knock-out strategies are lim-
ited to host factors with non-essential endogenous function and
similar to RNAi compensatory effects can occur, a genetically clean
knock-out system holds the promise of unambiguously deﬁning
essential virus entry factors. Future studies will show whether
knockout screens have higher reproducibility than RNAi screens
and are suitable for virus entry research.
Both techniques, RNAi and CRISPR-Cas9, display speciﬁc advan-
tages and disadvantages, as reviewed in (Boettcher and McManus,
2015). Therefore, the appropriate technique, including small
molecule inhibitors, dominant negative variants and blocking anti-
bodies, has to be chosen carefully depending on the experimental
setup and the target genes.
After hypothesis testing, drug targets can be deﬁned and
searches for compounds interfering with critical network nodes ini-
tiated. Alternatively, novel baits can be selected and fueled into a
new round of AE-MS, thereby widening the interaction network.
Such iterative processes will ultimately complete the picture of PPI
during virus invasion (Fig. 4).
6. Beneﬁts and shortcomings of proteomics approaches
Proteomics is the only method to directly characterize the bio-
logically active entity of most biological processes, the proteins. In
an AE setup, it provides information on primary protein interac-
tions and higher order complexes depending on the stringency of
puriﬁcation. It can further yield the order of binding as well as inter-
action interfaces, when crosslinkers are used (Chen et al., 2010;
Leitner et al., 2010). As detailed above, interaction proteomics can
reveal receptor complex stoichiometry as well as PTM of the ana-
lyzed proteins. With increasing instrument sensitivity not only
stable protein interactions, but also transient and virus-induced
interactions are accessible. Protein networks between two cellular
G. Gerold et al. / Virus Research 218 (2016) 25–39 35
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tates, e.g., with and without receptor bound virus, can be com-
ared in a quantitative manner. In the past, detection of subtle
ifferences in protein abundance required isotope labeling, but
abel-free methods are nowadays sensitive enough for most appli-
ations. A clear advantage over RNA interference or image-based
creens is that the host cell is in its endogenous state without
he requirement for labeling of proteins or change of their expres-
ion level. Recent developments moreover make proteomics high
hroughput screen compatible (Hosp et al., 2015), so that virus
ntry processes could be studied in a large panel of cell lines as
ell as in a time resolved manner.
As every method, proteomics has its own shortcomings. Cer-
ain proteins are detected as common contaminants and these false
ositives have to be eliminated using proper controls and by com-
arison to contaminant databases. When searching for interactions
f endogenous proteins, antibodies of high speciﬁcity are required.
n the future, CRISPR knockin methods might overcome this caveat
nd allow expression of afﬁnity tagged proteins from their natural
ocus. Alternatively, controlled expression systems, although not
nder endogenous gene control, can help express tagged proteins at
ndogenous levels. Clearly, interaction proteomics just highlights systems virology workﬂow.
one biological function of a given protein, i.e., its interaction net-
work. Thus the method should be considered as complimentary
tool in the virologist’s toolbox. To address whether an interaction
is critical for virus infection, follow up analysis using established
(RNAi, inhibitors, dominant negative mutants) or newly devel-
oped techniques (CRISPR) is needed. Nonetheless, we  believe that
interaction proteomics will prove essential to model molecular net-
works during virus infection, assign critical nodes, generate and
test hypotheses on the molecular function of the proteins in the
network and thereby reveal essential host factors, which can be
targeted by antiviral drugs.
7. Research perspective
Genetic screens identiﬁed numerous virus receptors, but their
actual binding to the respective virus has often not been formerly
proven. Quantitative interaction proteomics approaches hold the
promise of closing this gap of knowledge. Due  to technological and
computational developments in the past decade proteomics is now
on par with genomics and allows high throughout comprehensive
analyses of complex samples. Recently, a 96-well compatible and
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treamlined interaction proteomics protocol has been developed
Hosp et al., 2015). Given the fact that for many viruses the target
ells are either not known or are of multiple host and tissue origin,
he parallel analysis of many biological samples will in the future
llow proteomics screening approaches without prior knowledge
f receptor expression or susceptibility.
A second consequence of the vast increase in MS  sensitivity is
hat patient material and material from animal experiments, which
s typically limited, can be analyzed in depth. Transcriptomics data
nly accounts for a subset of pathogen induced changes in a host as
t lacks information on PTMs and PPI. Proteomics of ex vivo samples
hus holds the promise of providing a more complete picture of the
irus host interplay in an infected organism. It will be interesting
o demonstrate to what extend the changes in host and virus pro-
eomes observed thus far in cell culture models, reﬂect the in vivo
ituation.
Notably, proteomics can not only elucidate protein networks
uring virus infection, but also serve to identify diagnostic and
rognostic markers of virus infection and disease progression
Mancone et al., 2013; Rhea et al., 2010). It also allows the iden-
iﬁcation of targets of chemical compound libraries by interaction
roteomics (Ong et al., 2009). MS-based proteomics is thus valuable
or virologists with a molecular biology, cell biology, and clini-
al focus. We  believe that increasing availability of proteomics
ardware, protocols and analysis software is currently spurring a
hift from the largely genomics dominated ﬁeld of virus infection
esearch towards proteomic characterization of cellular perturba-
ions by viruses.
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